George W. Lloyd - 25 Jul 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Issuer symbol
RPRX
Transactions as of
25 Jul 2022
Net transactions value
-$3,248,199
Form type
4
Filing time
27 Jul 2022, 18:20:16 UTC
Previous filing
31 May 2022
Next filing
01 Aug 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Sale $839,066 -19,557 -4.5% $42.90 410,443 25 Jul 2022 By GWL 2014 G, LLC F1
transaction RPRX Class A Ordinary Shares Sale $477,642 -11,114 -4.6% $42.98 228,886 25 Jul 2022 By GWL 2020 G, LLC F2
transaction RPRX Class A Ordinary Shares Sale $234,223 -5,443 -1.3% $43.03 405,000 26 Jul 2022 By GWL 2014 G, LLC F3
transaction RPRX Class A Ordinary Shares Sale $598,824 -13,886 -5.8% $43.12 226,114 26 Jul 2022 By GWL 2020 G, LLC F4
transaction RPRX Class A Ordinary Shares Sale $1,094,055 -25,000 -6.2% $43.76 380,000 27 Jul 2022 By GWL 2014 G, LLC F5
transaction RPRX Class A Ordinary Shares Sale $4,390 -100 -0.04% $43.90 226,014 27 Jul 2022 By GWL 2020 G, LLC
holding RPRX Class A Ordinary Shares 495,860 25 Jul 2022 By GWL 2013 NG, LLC
holding RPRX Class A Ordinary Shares 3,000 25 Jul 2022 Direct
holding RPRX Class A Ordinary Shares 273,960 25 Jul 2022 By IRA
holding RPRX Class A Ordinary Shares 4,011 25 Jul 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.72 to $43.16 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.90 to $43.17 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.91 to $43.13 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.93 to $43.35 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.70 to $43.89 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

All reported transactions were effected pursuant to a 10b5-1 plan adopted by the reporting person on June 23, 2022.